← Leaderboards
Girish Vyas
University Of California San Francisco
$137,332
Attributed
$137,332
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$137,332 · 1
By mechanism
M01$137,332 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- Diane W. Wara$7,985,315
- Elliott P Vichinsky$12,339,152
- Mark A Jacobson$6,824,928
- Mandana Khalili$12,345,266
Others in their field
Top investigators on “Antiserum”
- Ralph S Baric · University Of North Carolina Chapel Hill$9,155,523
- Frank Porreca · University Of Arizona$5,160,749
- Rae Lyn Burke · Sri International$5,063,994
- Edward K Wakeland · University Of Texas Sw Med Ctr/Dallas$3,901,509
- Theoharis C Theoharides · Tufts University Boston$3,287,545
- Michael A. Lovett · University Of California Los Angeles$2,773,337
Research focus
AntiserumBlood ChemistryBlood TransfusionClinical ResearchClinical Trial Phase ICommunicable Disease ControlHepatitis BHepatitis B Virus GroupHuman SubjectHuman Therapy EvaluationImmunotherapyLiver Transplantation
Grant awards (4)
PREVENTING HEPATITIS B INFECTION IN LIVER TRANSPLANTATION$68,666
M01 · FY2002 · RR
PREVENTING HEPATITIS B INFECTION IN LIVER TRANSPLANTATION$68,666
M01 · FY2001 · RR
PREVENTING HEPATITIS B INFECTION IN LIVER TRANSPLANTATION$0
M01 · FY2001 · RR
PREVENTING HEPATITIS B INFECTION IN LIVER TRANSPLANTATION$0
M01 · FY2000 · RR